Graf Acquisition

YTD

ALL

Why Robinhood?

You can watch GFOR and buy or sell other stocks, ETFs, and their options commission-free!

About GFOR

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression.

CEO

Paul Y. Song, MD, PhD

CEOPaul Y. Song, MD, PhD

Employees

—

Employees—

Headquarters

Santa Ana, California

HeadquartersSanta Ana, California

Founded

Employees

—

Employees—

GFOR Key Statistics

Market cap

10.75M

Market cap10.75M

Price-Earnings ratio

-0.13

Price-Earnings ratio-0.13

Dividend yield

—

Dividend yield—

Average volume

184.72K

Average volume184.72K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.37

52 Week high$1.37

52 Week low

$0.0983

52 Week low$0.0983

People also own

Based on the portfolios of people who own GFOR. This list is generated using Robinhood data, and it’s not a recommendation.